Neurovascular conditions such as stroke and aneurysms are generally treated with tissue
plasminogen activators (tPAs). However, use of neurointerventional devices along with
the medication therapy is more effective in removing clots and reducing the risk of
early recurrence of the condition. Interventional neurology technology has been evolving
rapidly, which is resulting in demand shift from clipping to coiling, coated to bare
platinum coils, and so on.